PDCD1 and melanoma: Since the data of OC response to immunotherapy are not available, to solve this problem, we explored an online database—TIDE, then analyzed the data collected from the melanoma patients treated with anti-PD-1 or anti-CTLA4 alone from Gide et al. in the TIDE website (Gide et al., 2019).